Em. Sutkowski et al., IRREVERSIBLE INHIBITION OF FORSKOLIN INTERACTIONS WITH TYPE-I ADENYLYL-CYCLASE BY A 6-ISOTHIOCYANATE DERIVATIVE OF FORSKOLIN, Molecular pharmacology, 50(2), 1996, pp. 299-305
Forskolin (Fsk) has been demonstrated to interact directly with the en
zyme adenylyl cyclase (EC 4.6.1.1) in diverse tissues. However, the ab
ility of Fsk to bind to and activate adenylyl cyclase varies depending
on the tissue being studied. Different adenylyl cyclase subtypes have
been cloned and expressed in a recombinant Sf9 expression system. Thi
s provides an opportunity to study the effects of chemically reactive
derivatives of Fsk on individual adenylyl cyclase subtypes in the abse
nce of G(s alpha). Reaction of type I adenylyl cyclase with an isothio
cyanate derivative of Fsk N-(2-isothiocyanatoethyl)amino]carbonyl]fors
kolin) causes irreversible inhibition of Fsk binding with an IC50 of 3
00 nM and irreversible inhibition of Fsk activation with an IC50 of 10
mu M, suggesting that there are two sites of [N-(2-isothiocyanatoethy
l)amino]carbonyl]forskolin interaction. These studies establish the us
efulness of the isothiocyanate derivative of Fsk in localizing the sit
e(s) of Fsk interaction with type I adenylyl cyclase.